Barclays Maintains Overweight on Nuvei, Lowers Price Target to $32
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst John Coffey maintains an Overweight rating on Nuvei (NASDAQ:NVEI) but lowers the price target from $34 to $32.

March 11, 2024 | 10:49 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Barclays maintains an Overweight rating on Nuvei but lowers the price target from $34 to $32.
While the maintenance of an Overweight rating by Barclays indicates a positive outlook on Nuvei, the reduction in the price target from $34 to $32 suggests a tempered expectation for the stock's short-term performance. This mixed signal could lead to neutral market reaction in the short term as investors weigh the positive rating against the lowered price expectations.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100